Evidence map›Paper›PMID 26303068›Full record

ArticleJournal of the American Society of Nephrology : JASN2016

Three-Dimensional Morphology by Multiphoton Microscopy with Clearing in a Model of Cisplatin-Induced CKD.

Richard Torres, Heino Velazquez, John J Chang, Michael J Levene, Gilbert Moeckel, Gary V Desir, Robert Safirstein

Abstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. High-throughput, organ-scale 3D tubule tracking using TubuleMAP.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Understanding Cisplatin Pharmacokinetics and Toxicodynamics to Predict and Prevent Kidney Injury.The Journal of pharmacology and experimental therapeutics · 2024
    Review
  11. Article
  12. Rodent models of AKI and AKI-CKD transition: an update in 2024.American journal of physiology. Renal physiology · 2024
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Caught in the crossfire: cancer, cisplatin therapy, and kidney injury.American journal of physiology. Renal physiology · 2023
    Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Richard TorresDepartment of Laboratory Medicine, robert.safirstein@yale.edu richard.torres@yale.edu.
Heino VelazquezDepartment of Nephrology, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut; and Department of Internal Medicine, and.
John J ChangDepartment of Nephrology, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut; and Department of Internal Medicine, and.
Michael J LeveneApplikate Technologies, LLC, East Haven, Connecticut.
Gilbert MoeckelDepartment of Pathology, Yale University School of Medicine, New Haven, Connecticut;
Gary V DesirDepartment of Nephrology, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut; and Department of Internal Medicine, and.
Robert SafirsteinDepartment of Nephrology, Veterans Affairs Connecticut Healthcare System, West Haven, Connecticut; and Department of Internal Medicine, and robert.safirstein@yale.edu richard.torres@yale.edu.
VA Connecticut Healthcare System · USYale University · US

Funding

Renal Physiology and Phenotyping CoreP30DK079310 · NIDDK · YALE UNIVERSITY · PI ARONSON, PETER S. · 2008 to 2022
$16.8M
Yale Mouse Metabolic Phenotyping CenterU24DK059635 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 2001 to 2015
$8.9M
Practical high resolution microscopy of un-cut, un-embedded lung biopsiesR43CA189522 · NCI · APPLIKATE TECHNOLOGIES, INC. · PI LEVENE, MICHAEL JOHN, TORRES, RICHARD · 2014 to 2014
$225k
Therapeutic Utility of renalase and renalase peptides in cisplatin-mediated renalR41CA189537 · NCI · BESSOR PHARMA, LLC · PI DESIR, GARY V. · 2014 to 2014
$219k
NCI NIH HHS 1R41CA189537-01NCI NIH HHS R41 CA189537NCI NIH HHS R43 CA189522NIDDK NIH HHS P30 DK079310NIDDK NIH HHS P30-DK079310NIDDK NIH HHS U24 DK059635NIDDK NIH HHS U24-DK059635
6 · The paper itself

Abstract

Traditional histologic methods are limited in their ability to detect pathologic changes of CKD, of which cisplatin therapy is an important cause. In addition, poor reproducibility of available methods has limited analysis of the role of fibrosis in CKD. Highly labor-intensive serial sectioning studies have demonstrated that three-dimensional perspective can reveal useful morphologic information on cisplatin-induced CKD. By applying the new technique of multiphoton microscopy (MPM) with clearing to a new mouse model of cisplatin-induced CKD, we obtained detailed morphologic and collagen reconstructions of millimeter-thick renal sections that provided new insights into pathophysiology. Quantitative analysis revealed that a major long-term cisplatin effect is reduction in the number of cuboidal cells of the glomerular capsule, a change we term the "uncapped glomerulus lesion." Glomerulotubular disconnection was confirmed, but connection remnants between damaged tubules and atubular glomeruli were observed. Reductions in normal glomerular capsules corresponded to reductions in GFR. Mild increases in collagen were noted, but the fibrosis was not spatially correlated with atubular glomeruli. Glomerular volume and number remained unaltered with cisplatin exposure, but cortical tubulointerstitial mass decreased. In conclusion, new observations were made possible by using clearing MPM, demonstrating the utility of this technique for studies of renal disease. This technique should prove valuable for further characterizing the evolution of CKD with cisplatin therapy and of other conditions.

Indexed as

Imaging, Three-DimensionalMicroscopy, Fluorescence, MultiphotonAnimalsCisplatinDisease Models, AnimalMiceRenal Insufficiency, ChronicCisplatinchronic renal failurecisplatin nephrotoxicityhistopathologypathologyrenal microscopyrenal pathology

Identifiers

PMID26303068
PMCPMC4814184
OpenAlexW1954201158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.